Orchid Pharma Limited (ORCHPHARMA.NS)
INR 1794.0
(0.9%)
INR 1794.0
(0.9%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 8.19 Billion | 6.65 Billion | 5.59 Billion | 4.5 Billion | 5.08 Billion | 5.99 Billion |
| Cost of Revenue | 5.87 Billion | 3.84 Billion | 3.26 Billion | 2.39 Billion | 2.67 Billion | 3.11 Billion |
| Gross Profit | 2.32 Billion | 2.81 Billion | 2.33 Billion | 2.1 Billion | 2.4 Billion | 2.88 Billion |
| Operating Expenses | 800.77 Million | 1.2 Billion | 2.65 Billion | 2.59 Billion | 3.72 Billion | 3.62 Billion |
| Selling, General and Administrative Expenses | 729.83 Million | 231.22 Million | 311.6 Million | 263.5 Million | 331.91 Million | 246.38 Million |
| Research and Development Expenses | 70.93 Million | 63.62 Million | 66.26 Million | 48.09 Million | 119.28 Million | 139.61 Million |
| Other Expenses | - | -1.12 Billion | 4.89 Million | 4.8 Million | 2.24 Million | 18.39 Million |
| Cost and Expenses | 5.83 Billion | 5.04 Billion | 5.91 Billion | 4.99 Billion | 6.39 Billion | 6.73 Billion |
| Operating Income | 2.36 Billion | 289.92 Million | -338.89 Million | -504.94 Million | -721.75 Million | -736.56 Million |
| Interest Expense | 167.35 Million | 322.25 Million | 320.11 Million | 513.35 Million | 41.58 Million | 2.99 Million |
| Income Tax Expense | -31.19 Million | 260.44 Million | -499.8 Million | 259.06 Million | 65.53 Million | -569.67 Million |
| Earnings before Tax | 919.45 Million | 552.46 Million | -568.98 Million | -952.48 Million | -1.31 Billion | 694.07 Million |
| Net Income | 921.66 Million | 463.18 Million | -19.51 Million | -1.16 Billion | -1.31 Billion | 694.07 Million |
| Earnings Per Share Basic | 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.80 |
| Earnings Per Share Diluted | 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.80 |
| Weighted Average Shares Outstanding | 48.36 Million | 40.81 Million | 40.81 Million | 40.81 Million | 88.83 Million | 88.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.36 Million | 40.81 Million | 40.81 Million | 40.81 Million | 88.83 Million | 88.98 Million |
| Gross Margin | 0.28 | 0.42 | 0.42 | 0.47 | 0.47 | 0.48 |
| EBIT Margin | 0.17 | 0.15 | 0.11 | 0.14 | -0.00 | -0.00 |
| Profit Margin | 0.11 | 0.07 | -0.00 | -0.26 | -0.26 | 0.12 |
| EBITDA | 1.41 Billion | 1.42 Billion | 635.81 Million | 658.73 Million | 544.65 Million | 2.06 Billion |
| Earnings Before Tax Margin | 0.29 | 0.04 | -0.06 | -0.11 | -0.14 | -0.12 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.44 Billion | 8.19 Billion | 2.17 Billion | 2.2 Billion | 1.98 Billion | 1.82 Billion |
| Cost of Revenue | 1.8 Billion | 5.87 Billion | 1.54 Billion | 1.21 Billion | 1.22 Billion | 1.12 Billion |
| Gross Profit | 637.06 Million | 2.32 Billion | 629.93 Million | 986.52 Million | 764.25 Million | 708.52 Million |
| Operating Expenses | 396.58 Million | 1.54 Billion | 424.94 Million | 284.09 Million | 609.22 Million | 564.17 Million |
| Selling, General and Administrative Expenses | 396.58 Million | - | 424.94 Million | 441.21 Million | 355.52 Million | 162.2 Million |
| Research and Development Expenses | - | - | 70.93 Million | - | - | - |
| Other Expenses | 75.7 Million | -1.23 Billion | -294.24 Million | -365.06 Million | 83.55 Million | 18.85 Million |
| Cost and Expenses | 2.2 Billion | 7.41 Billion | 1.96 Billion | 1.5 Billion | 1.83 Billion | 1.68 Billion |
| Operating Income | 240.48 Million | 774.36 Million | 204.98 Million | 337.36 Million | 238.28 Million | 144.34 Million |
| Interest Expense | 34.98 Million | 163.54 Million | 34.6 Million | 35.43 Million | 38.04 Million | 55.45 Million |
| Income Tax Expense | -1.54 Million | -31.19 Million | -31.19 Million | 7.61 Million | 2.2 Million | 18.85 Million |
| Earnings before Tax | 281.2 Million | 919.45 Million | 303.82 Million | 301.92 Million | 200.23 Million | 107.75 Million |
| Net Income | 293.5 Million | 921.66 Million | 335.26 Million | 294.31 Million | 198.03 Million | 94.04 Million |
| Earnings Per Share Basic | 5.79 | - | 6.81 | 5.80 | 3.90 | 1.85 |
| Earnings Per Share Diluted | 5.79 | - | 6.81 | 5.80 | 3.90 | 1.85 |
| Weighted Average Shares Outstanding | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million | 50.71 Million |
| Gross Margin | 0.26 | 0.28 | 0.29 | 0.45 | 0.38 | 0.39 |
| EBIT Margin | 0.13 | - | 0.13 | 0.19 | 0.16 | 0.13 |
| Profit Margin | 0.12 | 0.11 | 0.15 | 0.13 | 0.10 | 0.05 |
| EBITDA | 324.91 Million | - | 289.18 Million | 430.05 Million | 316.69 Million | 240.28 Million |
| Earnings Before Tax Margin | 0.10 | 0.09 | 0.09 | 0.15 | 0.12 | 0.08 |
SKHCF
CDGLY
MDTR
ZOREN
600703
8960